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 Photodynamic therapy (PDT) is a combination of light and photosensitizing drug in which 
a photosensitizer is injected intravenously and accumulates in the tissue. This tissue is then 
irradiated by light at an appropriate wavelength and the drug leads to cytotoxicity with a cascade 
of biochemical responses which affects and inactivates the cancer cells in the tumor tissue.1 In 
the cells, PDT generally induces mitochondrial damage and apoptosis which destroy the tissue 
and induce an antitumor activity upon illumination.2  
 Benzoporphyrin-derivative verteporfin (BPD) and curcumin are two photosensitizer drugs 
having the capability in use of PDT. The therapeutic potential of BPD and curcumin as 
photosensitizers is limited by their low aqueous solubility and applicability. In this study, it is 
aimed to increase the bioavailability of these drugs to induce antitumor activity in the tumor 
cells. Liposomes and PLGA-based polymeric nanoparticles (PLGA NPs) are used as the drug 
carrier nanoparticles which have been considered as perfect carriers for cancer therapeutics 
and they are remarkably used in cancer therapy.3,4 BPD and curcumin-loaded liposomes and 
PLGA NPs were synthesized and characterized in terms of size, zeta potential, drug 
encapsulation efficiency and morphology. These nanoparticles were targeted towards breast 
cancer cell line (MDA-MB-231) in vitro MTS cytotoxicity assays and imaging. 
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